HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK548.79m
- NOK778.72m
- NOK256.34m
Brief: Hofseth Biocare Names Jon Olav Ødegård New CEO
Brief: Hofseth Biocare Places Shares Of NOK 141 Mln
Brief: Hofseth Biocare Contemplates Private Placement
Brief: Hofseth Biocare: Result Of The Subsequent Offering
Brief: Hofseth Biocare And Tenet Partners Initiate Long-Term Collaboration
Brief: Hofseth Biocare Signs Pan-Asian Distribution Contract With DKSH
Brief: Hofseth Biocare Signs Agreement With IMCD
Brief: Hofseth Biocare Q3 EBITDA Loss Widens To NOK 23.2 Mln
Brief: Hofseth Biocare Gets Approval From Health Canada For Qualified Health Claims For Its Salmon Protein Hydrolysate
Brief: Hofseth Biocare Says Private Placement Significantly Oversubscribed
Brief: Hofseth Biocare: New Study Shows Potential Of Omego As Therapy For Asthma And COPD
Brief: Hofseth Biocare Q2 EBITDA Loss NOK 17.3 Million
Brief: Hofseth Biocare Secures Distribution With Global Retailer Giant In UK, Spain, Iceland
Brief: Hofseth Biocare Buys 34% Stake In Atlantic Delights
Brief: Hofseth Biocare ASA: HBC Has Begun Protocol Development For Its Accelerated Phase 2 Clinical Trial
Brief: Hofseth Biocare: Preclinical Research With OmeGo Demonstrates Potential To Treat Eosinophilic Asthma
Brief: Hofseth Biocare ASA - Operating Revenues Of Nok 18.5 mln Q1 Of 2020
Brief: Hofseth Biocare: Two-Year Research Collaboration Contract Signed With Stanford
Australia's Clean Seas Seafood rises on investment from Norway-based Hofseth